Literature DB >> 9024376

Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.

A G Roberts1, S D Whatley, R R Morgan, M Worwood, G H Elder.   

Abstract

BACKGROUND: Sporadic porphyria cutanea tarda is a skin disease associated with hepatic siderosis. Depletion of iron stores by phlebotomy is curative. The role of haemochromatosis genes in determining susceptibility to this disorder is controversial. We have examined the frequency in sporadic porphyria cutanea tarda of mutations (Cys282Tyr, His63Asp) in a novel MHC class-I-like gene, one of which (Cys282Tyr) is believed to cause haemochromatosis.
METHODS: 41 patients with sporadic porphyria cutanea tarda, in whom the frequency of microsatellite alleles that define the ancestral haemochromatosis haplotype had previously been determined, and 101 healthy blood donors were studied for the presence of the Cys282Tyr and His63Asp mutations. We used restriction-enzyme digestion of PCR-amplified genomic DNA.
FINDINGS: The Cys282Tyr mutation occurred in 18 (44%) of patients compared with 11 (11%) of controls (relative risk 6.2, 95% CI 2.6-14.5, p = 0.00003). Seven (17%) patients, aged 48-79 years, were homozygotes. In 12 patients, the Cys282Tyr mutation was associated with markers of the HLA-A3-containing ancestral haemochromatosis haplotype. Ages at presentation were the same for those with or without the Cys282Tyr mutation. There was no difference in the frequency of the His63Asp mutation.
INTERPRETATION: Inheritance of one or more haemochromatosis genes is an important susceptibility factor for sporadic porphyria cutanea tarda. Some homozygotes for the Cys282Tyr mutation present late in life with porphyria cutanea tarda, indicating that not all homozygotes present clinically with haemochromatosis. The relation between this genotype and disease needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024376     DOI: 10.1016/S0140-6736(96)09436-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda.

Authors:  L Christiansen; A Bygum; A Jensen; K Thomsen; F Brandrup; M Hørder; N E Petersen
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

2.  Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.

Authors:  P D Jensen; F T Jensen; T Christensen; L Heickendorff; L G Jensen; J Ellegaard
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

3.  Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?

Authors:  P Aguilar-Martinez; M Bismuth; M C Picot; C Thelcide; G P Pageaux; F Blanc; P Blanc; J F Schved; D Larrey
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  Down-regulation of hepcidin in porphyria cutanea tarda.

Authors:  Richard S Ajioka; John D Phillips; Robert B Weiss; Diane M Dunn; Maria W Smit; Sean C Proll; Michael G Katze; James P Kushner
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

5.  The significance of the 187G (H63D) mutation in hemochromatosis.

Authors:  E Beutler
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

6.  Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary haemochromatosis.

Authors:  D Baty; A Terron Kwiatkowski; D Mechan; A Harris; M J Pippard; D Goudie
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

7.  Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis.

Authors:  J P Kaltwasser; E Werner; K Schalk; C Hansen; R Gottschalk; C Seidl
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

9.  Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Authors:  Sven G Gehrke; Wolfgang Stremmel; Inge Mathes; Hans-Dieter Riedel; Karin Bents; Birgit Kallinowski
Journal:  J Mol Med (Berl)       Date:  2003-10-14       Impact factor: 4.599

10.  Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.

Authors:  M Mendez; L Sorkin; M V Rossetti; K H Astrin; A M del C Batlle; V E Parera; G Aizencang; R J Desnick
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.